Overall, the Oyikey SMGT GLP-1 patch has numerous signs of being an unethical, unproven product, and possibly an outright scam
In these studies, obese participants received 2.5 mg tirzepatide SC QWK for four weeks, followed by four weeks of 2.5 mg tirzepatide SC QWK and/or 1.25 mg bremelanotide SC QD, and finally four additional weeks without any treatment
PubMed: Physiology of the weight loss plateau , detailing the quantitative relationships between weight lost, metabolic adaptation, and the timeline of plateau onset across different intervention types
Nonetheless, the overlap between GLP-1 side effects and IBS symptoms means we need to look carefully at how these medications might exacerbate or alleviate IBS in different scenarios
Fan Y, Wu D, Jin L, Yin Z
Reach out to our legal team now